闭合性颅脑损伤小鼠模型中皮层扩散性去极化、血流与认知结局
研究采用成年雄性C57Bl/6J小鼠(8–14周龄),异氟烷麻醉后以81 g重物从152或183 cm高度坠落造成闭合性颅脑损伤(CHI),用微创可见光光学内源信号成像检测皮层扩散性去极化(CSD),并在152 cm组用弥散相关光谱测脑血流指数(CBFi)。152 cm组CSD发生率43%(28只中12只),183 cm组58%(26只中15只),p=0.28。伤前基线CBFi较低与CSD发生相关(CSD-组1.50±0.07×10-7 vs CSD+组1.17±0.04×10-7,p=0.0001);发生CSD者同侧半球伤后/伤前CBFi比值较非CSD半球低0.19±0.07(p=0.028)。152 cm组4周Morris水迷宫各测试无差异;183 cm组CSD+小鼠1–2周隐藏平台测试差于假手术组(p=0.045),但与CSD-组无明显差异。作者认为伤前低脑血流可能促进CSD发生,适当实验条件下CSD可与更差认知结局相关。
要点
- 小鼠CHI后CSD发生率:152 cm坠落组43%(28只中12只),183 cm组58%(26只中15只),两组差异无统计学显著(p=0.28)。
- 伤前基线CBFi较低与CHI后发生CSD相关:CSD-组1.50±0.07×10-7 vs CSD+组1.17±0.04×10-7(p=0.0001)。
- 发生CSD的小鼠中,CSD同侧半球伤后/伤前CBFi比值较非CSD半球低0.19±0.07(p=0.028)。
- 152 cm坠落高度下,假手术组(n=10)、CHI CSD+组(n=12)与CHI CSD-组(n=16)4周Morris水迷宫测试无差异。
- 183 cm坠落高度下,CHI CSD+组(n=15)1–2周隐藏平台测试差于假手术组(n=9)(p=0.045),但与CHI CSD-组(n=11)无明显差异。
适用人群与场景
- 成年雄性C57Bl/6J小鼠,8–14周龄,异氟烷麻醉下接受81 g重物从152或183 cm高度坠落的闭合性颅脑损伤(CHI)模型。
- 认知结局评估纳入152 cm和183 cm坠落高度的CHI小鼠及相应假手术组。
研究设计与关键结果
- 研究类型:小鼠闭合性颅脑损伤(CHI)模型实验;样本:152 cm组28只、183 cm组26只接受CHI,另设假手术组。
- CSD发生率:152 cm组43%(28只中12只) vs 183 cm组58%(26只中15只),p=0.28。
- 伤前基线CBFi:CHI无CSD组(CSD-)1.50±0.07×10-7 vs CHI有CSD组(CSD+)1.17±0.04×10-7,p=0.0001。
- CSD+小鼠中,CSD同侧半球伤后/伤前CBFi比值较非CSD半球低0.19±0.07(p=0.028)。
- 152 cm坠落高度:假手术组(n=10)、CHI CSD+组(n=12)、CHI CSD-组(n=16)在4周Morris水迷宫测试中无 detectable 差异。
- 183 cm坠落高度:CHI CSD+组(n=15)1–2周隐藏平台测试差于假手术组(n=9),p=0.045;与CHI CSD-组(n=11)无明显差异。
证据类型、等级与局限
- 证据类型:动物实验(小鼠CHI模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,伤前基线脑血流较低可能促进CSD发生,适当实验条件下CSD可与更差认知结局相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Cortical spreading depolarizations (CSDs) are associated with worse outcomes in many forms of acute brain injury, including traumatic brain injury (TBI). Animal models could be helpful in developing new therapies or biomarkers to improve outcomes in survivors of TBI. Recently, investigators have observed CSDs in murine models of mild closed head injury (CHI). We designed the currently study to determine additional experimental conditions under which CSDs can be observed, from mild to relatively more severe TBI.
METHODS: Adult male C57Bl/6J mice (8-14 weeks old) were anesthetized with isoflurane and subjected to CHI with an 81-g weight drop from 152 or 183 cm. CSDs were detected with minimally invasive visible light optical intrinsic signal imaging. Cerebral blood flow index (CBFi) was measured in the 152-cm drop height cohort using diffuse correlation spectroscopy at baseline before and 4 min after CHI. Cognitive outcomes were assessed at 152- and 183-cm drop heights for the Morris water maze hidden platform, probe, and visible platform tests.
RESULTS: CSDs occurred in 43% (n = 12 of 28) of 152-cm and 58% (n = 15 of 26) of 183-cm drop height CHI mice (p = 0.28). A lower baseline preinjury CBFi was associated with development of CSDs in CHI mice (1.50 ± 0.07 × 10-7 CHI without CSD [CSD-] vs. 1.17 ± 0.04 × 10-7 CHI with CSD [CSD+], p = 0.0001). Furthermore, in CHI mice that developed CSDs, the ratio of post-CHI to pre-CHI CBFi was lower in the hemisphere ipsilateral to a CSD compared with non-CSD hemispheres (0.19 ± 0.07 less in the CSD hemisphere, p = 0.028). At a 152-cm drop height, there were no detectable differences between sham injured (n = 10), CHI CSD+ (n = 12), and CHI CSD- (n = 16) mice on Morris water maze testing at 4 weeks. At a 183-cm drop height, CHI CSD+ mice had worse performance on the hidden platform test at 1-2 weeks versus sham mice (n = 15 CHI CSD+, n = 9 sham, p = 0.045), but there was no appreciable differences compared with CHI CSD- mice (n = 11 CHI CSD-).
CONCLUSIONS: The data suggest that a lower baseline cerebral blood flow prior to injury may contribute to the occurrence of a CSD. Furthermore, a CSD at the time of injury can be associated with worse cognitive outcome under the appropriate experimental conditions in a mouse CHI model of TBI.
参考来源
- Mosley N, Chung JY, Jin G, et al. Cortical Spreading Depolarization, Blood Flow, and Cognitive Outcomes in a Closed Head Injury Mouse Model of Traumatic Brain Injury. Neurocrit Care. 2022. PMID: 35378664. doi:10.1007/s12028-022-01474-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。